{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:07:57Z","timestamp":1769202477604,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.jneuroim.2003.12.010","type":"journal-article","created":{"date-parts":[[2004,2,6]],"date-time":"2004-02-06T05:17:37Z","timestamp":1076044657000},"page":"182-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis"],"prefix":"10.1016","volume":"149","author":[{"given":"Koichi","family":"Narikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Misu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuto","family":"Itoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2003.12.010_BIB1","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR-5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1\u03b1 and IP-10 are expressed in demyelinating brain lesions","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-5728(01)00261-2","article-title":"Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies","volume":"115","author":"Franciotta","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines-chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1044-5323(02)00125-2","article-title":"The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)","volume":"15","author":"Mahad","year":"2003","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-5728(00)00456-2","article-title":"Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1\/Th2-associated chemokine signaling","volume":"114","author":"Misu","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB8","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/brain\/awf260","article-title":"Pure optic-spinal form of multiple sclerosis in Japan","volume":"125","author":"Misu","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/WNL.62.1.144","article-title":"Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica","volume":"62","author":"Nakashima","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.60.4.382","article-title":"Clinical, CSF, and MRI findings in Devic's neuromyelitis optica","volume":"60","author":"O'Riordan","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0167-5699(98)01346-2","article-title":"Chemokines and chemokine receptors in T-cell priming and Th1\/Th2-mediated responses","volume":"19","author":"Sallusto","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(01)00680-3","article-title":"IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease","volume":"195","author":"Scarpini","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1034\/j.1600-0404.2001.104002088.x","article-title":"Differential release of beta-chemokines in serum and CSF of patients with relapsing\u2013remitting multiple sclerosis","volume":"104","author":"Sindern","year":"2001","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients","volume":"103","author":"S\u00f8rensen","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1468-1331.2001.00327.x","article-title":"Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis","volume":"8","author":"S\u00f8rensen","year":"2001","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2003.12.010_BIB16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572803005666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572803005666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:58:41Z","timestamp":1759046321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572803005666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":16,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0165572803005666"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2003.12.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2003.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}